Navigation Links
Neurotoxins might Reverse Mononeuronal Disease – Study Find

By making modifications in botox – an anti-wrinkle treatment, Dr Frederic Meunier, a winner of UniQuest's 2006 competition has developed a cure for motoneuronal diseases//.

Researcher used neurotoxins to form a selective motoneuron delivery system in the body, which blocked the unnecessary neuronal communications and thus assists in treating the motorneuron diseases.

Motoneuronal diseases cause a degeneration of the nerve pathways controlling muscle activity. The diseases are severe and physically debilitating disorders, which lead to progressive weakness and wasting of muscles. Many of the diseases are incurable.

Dr Meunier is developing botox to selectively deliver drugs to motoneurons to directly treat motorneuron diseases.

‘I first became interested in investigating neurotoxins because they are fantastic molecular tools to dissect synaptic mechanisms,’ Dr Meunier said.

‘The aim of our lab is to understand the molecular mechanism underlying neuronal communication. The legacy of millions of years of evolution and competition between venomous species has resulted in deadly neurotoxins capable of blocking neuronal communication. I am using our knowledge of the mode of action of these neurotoxins to design a selective motoneuron delivery system that could change our way of treating motoneuronal diseases.’

Dr Meunier's innovative research caught the attention of UQ's main commercialisation company, UniQuest Pty Ltd, which runs the annual Trailblazer competition.

UniQuest Managing Director David Henderson said the Trailblazer judges were impressed by Dr Meunier's research and the opportunities surrounding it.

‘The therapeutic applications of this research are important, as it could help prevent or cure motoneuronal diseases,’ Mr Henderson said.

‘Also, the research potentially has important applications for the treatment of other diseases.’

Source: Eurkalert
'"/>




Page: 1

Related medicine news :

1. Suicide might be inherited
2. Cleanliness might lead to Asthma
3. Stroke risk might be linked to antibody
4. Change in walking might indicate Dementia
5. Drug might prevent Prostate Cancer Spread
6. Diet might just have an Effect on Breast Cancer
7. Chlorine might be a cause for Asthma
8. Pill might be able to reduce the damage loud noise does to your hearing
9. Drug might prevent Prostate Cancer Spread
10. Women might be at increased risk of HIV during pregnancy
11. Older generation might pose a threat to increase the NHS budget
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2016)... ... 29, 2016 , ... Melanoma is the deadliest type of skin cancer. Although only about 1 ... skin cancer deaths. More than 10,000 people are expected to die of melanoma this year. ... is the one of the most commonly diagnosed cancers in young women. A recent breakthrough ...
(Date:4/29/2016)... ... April 29, 2016 , ... Reltok Nasal Products proudly announces that Boston ... and neck/ear, nose and throat specialty, has added the KOTLER NASAL AIRWAY™ to its ... is a newly patented safety device secured by nasal surgeons onto the floor ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... Dairy Products, Inc. in an upcoming episode, airing third quarter 2016 via Discovery ... churning cream into butter, Grassland Dairy Products, located in Greenwood, Wisconsin applies product ...
(Date:4/29/2016)... ... April 29, 2016 , ... The infertility specialists at HRC Fertility/Orange County ... Dr. Daniel A. Potter -- are proud of the recent release of their 2014 ... April, SART published the latest verified data for 375 U.S. member clinics. ...
(Date:4/29/2016)... ... 29, 2016 , ... International Dehydrated Foods, Inc. (IDF™) will attend and sponsor ... the Doubletree by Hilton Hotel in Oak Brook, Illinois. The two-day event is the ... protein ingredients. , At the seminar, IDF™ will offer samples of its Savory ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , Net Sales of $1.90 billion represent an increase ... period, and an increase of 1.2% on an adjusted pro ... first quarter were $0.52 reported, a decrease of 47.5% from ... 29.9% over the prior year period , The Company ... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) ...
(Date:4/28/2016)... April 28, 2016  ValGenesis, Inc., the ... Solutions (VLMS) today announced that a prominent ... sufferers of chronic kidney failure has selected ... their corporate validation process. The global medical ... solution to manage their validation processes electronically. ...
(Date:4/27/2016)... , Schweiz, April 27, 2016 /PRNewswire/ ... des Sachs CEO Forums in Zürich gab ... ihres führenden Wirkstoffkandidaten STR001 zur Erhaltung des ... eingesetzt wurde, bekannt. Für die umfassende Phase-II-Doppelblindstudie ... und Frankreich angeworben. STR001 wird während der ...
Breaking Medicine Technology: